Daytime Impact Sleep Study

NCT01779466 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to lack of eligible patients

Conditions

Nocturia

Interventions

DRUG: Desmopressin
DRUG: Placebo (not active)

Sponsor

Ferring Pharmaceuticals